Global Chronic Kidney Disease (CKD) Market Size, Status and Forecast 2023-2027

Report ID: 1012546 | Published Date: Jan 2025 | No. of Page: 107 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Chronic Kidney Disease (CKD) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 ACE Inhibitors
        1.2.3 Calcium Channel Blockers
        1.2.4 Beta Blockers
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Chronic Kidney Disease (CKD) Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals
        1.3.3 Specialty Clinics
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Chronic Kidney Disease (CKD) Market Perspective (2016-2027)
    2.2 Chronic Kidney Disease (CKD) Growth Trends by Regions
        2.2.1 Chronic Kidney Disease (CKD) Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Chronic Kidney Disease (CKD) Historic Market Share by Regions (2016-2021)
        2.2.3 Chronic Kidney Disease (CKD) Forecasted Market Size by Regions (2022-2027)
    2.3 Chronic Kidney Disease (CKD) Industry Dynamic
        2.3.1 Chronic Kidney Disease (CKD) Market Trends
        2.3.2 Chronic Kidney Disease (CKD) Market Drivers
        2.3.3 Chronic Kidney Disease (CKD) Market Challenges
        2.3.4 Chronic Kidney Disease (CKD) Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Chronic Kidney Disease (CKD) Players by Revenue
        3.1.1 Global Top Chronic Kidney Disease (CKD) Players by Revenue (2016-2021)
        3.1.2 Global Chronic Kidney Disease (CKD) Revenue Market Share by Players (2016-2021)
    3.2 Global Chronic Kidney Disease (CKD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Chronic Kidney Disease (CKD) Revenue
    3.4 Global Chronic Kidney Disease (CKD) Market Concentration Ratio
        3.4.1 Global Chronic Kidney Disease (CKD) Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Chronic Kidney Disease (CKD) Revenue in 2020
    3.5 Chronic Kidney Disease (CKD) Key Players Head office and Area Served
    3.6 Key Players Chronic Kidney Disease (CKD) Product Solution and Service
    3.7 Date of Enter into Chronic Kidney Disease (CKD) Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Chronic Kidney Disease (CKD) Breakdown Data by Type
    4.1 Global Chronic Kidney Disease (CKD) Historic Market Size by Type (2016-2021)
    4.2 Global Chronic Kidney Disease (CKD) Forecasted Market Size by Type (2022-2027)

5 Chronic Kidney Disease (CKD) Breakdown Data by Application
    5.1 Global Chronic Kidney Disease (CKD) Historic Market Size by Application (2016-2021)
    5.2 Global Chronic Kidney Disease (CKD) Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Chronic Kidney Disease (CKD) Market Size (2016-2027)
    6.2 North America Chronic Kidney Disease (CKD) Market Size by Type
        6.2.1 North America Chronic Kidney Disease (CKD) Market Size by Type (2016-2021)
        6.2.2 North America Chronic Kidney Disease (CKD) Market Size by Type (2022-2027)
        6.2.3 North America Chronic Kidney Disease (CKD) Market Size by Type (2016-2027)
    6.3 North America Chronic Kidney Disease (CKD) Market Size by Application
        6.3.1 North America Chronic Kidney Disease (CKD) Market Size by Application (2016-2021)
        6.3.2 North America Chronic Kidney Disease (CKD) Market Size by Application (2022-2027)
        6.3.3 North America Chronic Kidney Disease (CKD) Market Size by Application (2016-2027)
    6.4 North America Chronic Kidney Disease (CKD) Market Size by Country
        6.4.1 North America Chronic Kidney Disease (CKD) Market Size by Country (2016-2021)
        6.4.2 North America Chronic Kidney Disease (CKD) Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Chronic Kidney Disease (CKD) Market Size (2016-2027)
    7.2 Europe Chronic Kidney Disease (CKD) Market Size by Type
        7.2.1 Europe Chronic Kidney Disease (CKD) Market Size by Type (2016-2021)
        7.2.2 Europe Chronic Kidney Disease (CKD) Market Size by Type (2022-2027)
        7.2.3 Europe Chronic Kidney Disease (CKD) Market Size by Type (2016-2027)
    7.3 Europe Chronic Kidney Disease (CKD) Market Size by Application
        7.3.1 Europe Chronic Kidney Disease (CKD) Market Size by Application (2016-2021)
        7.3.2 Europe Chronic Kidney Disease (CKD) Market Size by Application (2022-2027)
        7.3.3 Europe Chronic Kidney Disease (CKD) Market Size by Application (2016-2027)
    7.4 Europe Chronic Kidney Disease (CKD) Market Size by Country
        7.4.1 Europe Chronic Kidney Disease (CKD) Market Size by Country (2016-2021)
        7.4.2 Europe Chronic Kidney Disease (CKD) Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Chronic Kidney Disease (CKD) Market Size (2016-2027)
    8.2 Asia-Pacific Chronic Kidney Disease (CKD) Market Size by Type
        8.2.1 Asia-Pacific Chronic Kidney Disease (CKD) Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Chronic Kidney Disease (CKD) Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Chronic Kidney Disease (CKD) Market Size by Type (2016-2027)
    8.3 Asia-Pacific Chronic Kidney Disease (CKD) Market Size by Application
        8.3.1 Asia-Pacific Chronic Kidney Disease (CKD) Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Chronic Kidney Disease (CKD) Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Chronic Kidney Disease (CKD) Market Size by Application (2016-2027)
    8.4 Asia-Pacific Chronic Kidney Disease (CKD) Market Size by Region
        8.4.1 Asia-Pacific Chronic Kidney Disease (CKD) Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Chronic Kidney Disease (CKD) Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Chronic Kidney Disease (CKD) Market Size (2016-2027)
    9.2 Latin America Chronic Kidney Disease (CKD) Market Size by Type
        9.2.1 Latin America Chronic Kidney Disease (CKD) Market Size by Type (2016-2021)
        9.2.2 Latin America Chronic Kidney Disease (CKD) Market Size by Type (2022-2027)
        9.2.3 Latin America Chronic Kidney Disease (CKD) Market Size by Type (2016-2027)
    9.3 Latin America Chronic Kidney Disease (CKD) Market Size by Application
        9.3.1 Latin America Chronic Kidney Disease (CKD) Market Size by Application (2016-2021)
        9.3.2 Latin America Chronic Kidney Disease (CKD) Market Size by Application (2022-2027)
        9.3.3 Latin America Chronic Kidney Disease (CKD) Market Size by Application (2016-2027)
    9.4 Latin America Chronic Kidney Disease (CKD) Market Size by Country
        9.4.1 Latin America Chronic Kidney Disease (CKD) Market Size by Country (2016-2021)
        9.4.2 Latin America Chronic Kidney Disease (CKD) Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Chronic Kidney Disease (CKD) Market Size (2016-2027)
    10.2 Middle East & Africa Chronic Kidney Disease (CKD) Market Size by Type
        10.2.1 Middle East & Africa Chronic Kidney Disease (CKD) Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Chronic Kidney Disease (CKD) Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Chronic Kidney Disease (CKD) Market Size by Type (2016-2027)
    10.3 Middle East & Africa Chronic Kidney Disease (CKD) Market Size by Application
        10.3.1 Middle East & Africa Chronic Kidney Disease (CKD) Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Chronic Kidney Disease (CKD) Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Chronic Kidney Disease (CKD) Market Size by Application (2016-2027)
    10.4 Middle East & Africa Chronic Kidney Disease (CKD) Market Size by Country
        10.4.1 Middle East & Africa Chronic Kidney Disease (CKD) Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Chronic Kidney Disease (CKD) Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 AbbVie
        11.1.1 AbbVie Company Details
        11.1.2 AbbVie Business Overview
        11.1.3 AbbVie Chronic Kidney Disease (CKD) Introduction
        11.1.4 AbbVie Revenue in Chronic Kidney Disease (CKD) Business (2016-2021)
        11.1.5 AbbVie Recent Development
    11.2 Allergan
        11.2.1 Allergan Company Details
        11.2.2 Allergan Business Overview
        11.2.3 Allergan Chronic Kidney Disease (CKD) Introduction
        11.2.4 Allergan Revenue in Chronic Kidney Disease (CKD) Business (2016-2021)
        11.2.5 Allergan Recent Development
    11.3 Amgen
        11.3.1 Amgen Company Details
        11.3.2 Amgen Business Overview
        11.3.3 Amgen Chronic Kidney Disease (CKD) Introduction
        11.3.4 Amgen Revenue in Chronic Kidney Disease (CKD) Business (2016-2021)
        11.3.5 Amgen Recent Development
    11.4 AstraZeneca
        11.4.1 AstraZeneca Company Details
        11.4.2 AstraZeneca Business Overview
        11.4.3 AstraZeneca Chronic Kidney Disease (CKD) Introduction
        11.4.4 AstraZeneca Revenue in Chronic Kidney Disease (CKD) Business (2016-2021)
        11.4.5 AstraZeneca Recent Development
    11.5 Roche
        11.5.1 Roche Company Details
        11.5.2 Roche Business Overview
        11.5.3 Roche Chronic Kidney Disease (CKD) Introduction
        11.5.4 Roche Revenue in Chronic Kidney Disease (CKD) Business (2016-2021)
        11.5.5 Roche Recent Development
    11.6 FibroGen
        11.6.1 FibroGen Company Details
        11.6.2 FibroGen Business Overview
        11.6.3 FibroGen Chronic Kidney Disease (CKD) Introduction
        11.6.4 FibroGen Revenue in Chronic Kidney Disease (CKD) Business (2016-2021)
        11.6.5 FibroGen Recent Development
    11.7 GlaxoSmithKline
        11.7.1 GlaxoSmithKline Company Details
        11.7.2 GlaxoSmithKline Business Overview
        11.7.3 GlaxoSmithKline Chronic Kidney Disease (CKD) Introduction
        11.7.4 GlaxoSmithKline Revenue in Chronic Kidney Disease (CKD) Business (2016-2021)
        11.7.5 GlaxoSmithKline Recent Development
    11.8 Johnson & Johnson
        11.8.1 Johnson & Johnson Company Details
        11.8.2 Johnson & Johnson Business Overview
        11.8.3 Johnson & Johnson Chronic Kidney Disease (CKD) Introduction
        11.8.4 Johnson & Johnson Revenue in Chronic Kidney Disease (CKD) Business (2016-2021)
        11.8.5 Johnson & Johnson Recent Development
    11.9 Keryx
        11.9.1 Keryx Company Details
        11.9.2 Keryx Business Overview
        11.9.3 Keryx Chronic Kidney Disease (CKD) Introduction
        11.9.4 Keryx Revenue in Chronic Kidney Disease (CKD) Business (2016-2021)
        11.9.5 Keryx Recent Development
    11.10 Kissei
        11.10.1 Kissei Company Details
        11.10.2 Kissei Business Overview
        11.10.3 Kissei Chronic Kidney Disease (CKD) Introduction
        11.10.4 Kissei Revenue in Chronic Kidney Disease (CKD) Business (2016-2021)
        11.10.5 Kissei Recent Development
    11.11 Pfizer
        11.11.1 Pfizer Company Details
        11.11.2 Pfizer Business Overview
        11.11.3 Pfizer Chronic Kidney Disease (CKD) Introduction
        11.11.4 Pfizer Revenue in Chronic Kidney Disease (CKD) Business (2016-2021)
        11.11.5 Pfizer Recent Development
    11.12 Sanofi
        11.12.1 Sanofi Company Details
        11.12.2 Sanofi Business Overview
        11.12.3 Sanofi Chronic Kidney Disease (CKD) Introduction
        11.12.4 Sanofi Revenue in Chronic Kidney Disease (CKD) Business (2016-2021)
        11.12.5 Sanofi Recent Development
    11.13 Teva
        11.13.1 Teva Company Details
        11.13.2 Teva Business Overview
        11.13.3 Teva Chronic Kidney Disease (CKD) Introduction
        11.13.4 Teva Revenue in Chronic Kidney Disease (CKD) Business (2016-2021)
        11.13.5 Teva Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Chronic Kidney Disease (CKD) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of ACE Inhibitors
    Table 3. Key Players of Calcium Channel Blockers
    Table 4. Key Players of Beta Blockers
    Table 5. Key Players of Others
    Table 6. Global Chronic Kidney Disease (CKD) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Chronic Kidney Disease (CKD) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Chronic Kidney Disease (CKD) Market Size by Regions (2016-2021) & (US$ Million)
    Table 9. Global Chronic Kidney Disease (CKD) Market Share by Regions (2016-2021)
    Table 10. Global Chronic Kidney Disease (CKD) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 11. Global Chronic Kidney Disease (CKD) Market Share by Regions (2022-2027)
    Table 12. Chronic Kidney Disease (CKD) Market Trends
    Table 13. Chronic Kidney Disease (CKD) Market Drivers
    Table 14. Chronic Kidney Disease (CKD) Market Challenges
    Table 15. Chronic Kidney Disease (CKD) Market Restraints
    Table 16. Global Chronic Kidney Disease (CKD) Revenue by Players (2016-2021) & (US$ Million)
    Table 17. Global Chronic Kidney Disease (CKD) Market Share by Players (2016-2021)
    Table 18. Global Top Chronic Kidney Disease (CKD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Kidney Disease (CKD) as of 2020)
    Table 19. Ranking of Global Top Chronic Kidney Disease (CKD) Companies by Revenue (US$ Million) in 2020
    Table 20. Global 5 Largest Players Market Share by Chronic Kidney Disease (CKD) Revenue (CR5 and HHI) & (2016-2021)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Chronic Kidney Disease (CKD) Product Solution and Service
    Table 23. Date of Enter into Chronic Kidney Disease (CKD) Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Chronic Kidney Disease (CKD) Market Size by Type (2016-2021) (US$ Million)
    Table 26. Global Chronic Kidney Disease (CKD) Revenue Market Share by Type (2016-2021)
    Table 27. Global Chronic Kidney Disease (CKD) Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 28. Global Chronic Kidney Disease (CKD) Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 29. Global Chronic Kidney Disease (CKD) Market Size Share by Application (2016-2021) & (US$ Million)
    Table 30. Global Chronic Kidney Disease (CKD) Revenue Market Share by Application (2016-2021)
    Table 31. Global Chronic Kidney Disease (CKD) Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 32. Global Chronic Kidney Disease (CKD) Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 33. North America Chronic Kidney Disease (CKD) Market Size by Type (2016-2021) (US$ Million)
    Table 34. North America Chronic Kidney Disease (CKD) Market Size by Type (2022-2027) & (US$ Million)
    Table 35. North America Chronic Kidney Disease (CKD) Market Size by Application (2016-2021) (US$ Million)
    Table 36. North America Chronic Kidney Disease (CKD) Market Size by Application (2022-2027) & (US$ Million)
    Table 37. North America Chronic Kidney Disease (CKD) Market Size by Country (2016-2021) & (US$ Million) 
    Table 38. North America Chronic Kidney Disease (CKD) Market Size by Country (2022-2027) & (US$ Million) 
    Table 39. Europe Chronic Kidney Disease (CKD) Market Size by Type (2016-2021) (US$ Million)
    Table 40. Europe Chronic Kidney Disease (CKD) Market Size by Type (2022-2027) & (US$ Million)
    Table 41. Europe Chronic Kidney Disease (CKD) Market Size by Application (2016-2021) (US$ Million)
    Table 42. Europe Chronic Kidney Disease (CKD) Market Size by Application (2022-2027) & (US$ Million)
    Table 43. Europe Chronic Kidney Disease (CKD) Market Size by Country (2016-2021) & (US$ Million) 
    Table 44. Europe Chronic Kidney Disease (CKD) Market Size by Country (2022-2027) & (US$ Million) 
    Table 45. Asia-Pacific Chronic Kidney Disease (CKD) Market Size by Type (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Chronic Kidney Disease (CKD) Market Size by Type (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Chronic Kidney Disease (CKD) Market Size by Application (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Chronic Kidney Disease (CKD) Market Size by Application (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Chronic Kidney Disease (CKD) Market Size by Region (2016-2021) & (US$ Million) 
    Table 50. Asia-Pacific Chronic Kidney Disease (CKD) Market Size by Region (2022-2027) & (US$ Million) 
    Table 51. Latin America Chronic Kidney Disease (CKD) Market Size by Type (2016-2021) (US$ Million)
    Table 52. Latin America Chronic Kidney Disease (CKD) Market Size by Type (2022-2027) & (US$ Million)
    Table 53. Latin America Chronic Kidney Disease (CKD) Market Size by Application (2016-2021) (US$ Million)
    Table 54. Latin America Chronic Kidney Disease (CKD) Market Size by Application (2022-2027) & (US$ Million)
    Table 55. Latin America Chronic Kidney Disease (CKD) Market Size by Country (2016-2021) & (US$ Million) 
    Table 56. Latin America Chronic Kidney Disease (CKD) Market Size by Country (2022-2027) & (US$ Million) 
    Table 57. Middle East & Africa Chronic Kidney Disease (CKD) Market Size by Type (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Chronic Kidney Disease (CKD) Market Size by Type (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Chronic Kidney Disease (CKD) Market Size by Application (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Chronic Kidney Disease (CKD) Market Size by Application (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Chronic Kidney Disease (CKD) Market Size by Country (2016-2021) & (US$ Million) 
    Table 62. Middle East & Africa Chronic Kidney Disease (CKD) Market Size by Country (2022-2027) & (US$ Million) 
    Table 63. AbbVie Company Details
    Table 64. AbbVie Business Overview
    Table 65. AbbVie Chronic Kidney Disease (CKD) Product
    Table 66. AbbVie Revenue in Chronic Kidney Disease (CKD) Business (2016-2021) & (US$ Million)
    Table 67. AbbVie Recent Development
    Table 68. Allergan Company Details
    Table 69. Allergan Business Overview
    Table 70. Allergan Chronic Kidney Disease (CKD) Product
    Table 71. Allergan Revenue in Chronic Kidney Disease (CKD) Business (2016-2021) & (US$ Million)
    Table 72. Allergan Recent Development
    Table 73. Amgen Company Details
    Table 74. Amgen Business Overview
    Table 75. Amgen Chronic Kidney Disease (CKD) Product
    Table 76. Amgen Revenue in Chronic Kidney Disease (CKD) Business (2016-2021) & (US$ Million)
    Table 77. Amgen Recent Development
    Table 78. AstraZeneca Company Details
    Table 79. AstraZeneca Business Overview
    Table 80. AstraZeneca Chronic Kidney Disease (CKD) Product
    Table 81. AstraZeneca Revenue in Chronic Kidney Disease (CKD) Business (2016-2021) & (US$ Million)
    Table 82. AstraZeneca Recent Development
    Table 83. Roche Company Details
    Table 84. Roche Business Overview
    Table 85. Roche Chronic Kidney Disease (CKD) Product
    Table 86. Roche Revenue in Chronic Kidney Disease (CKD) Business (2016-2021) & (US$ Million)
    Table 87. Roche Recent Development
    Table 88. FibroGen Company Details
    Table 89. FibroGen Business Overview
    Table 90. FibroGen Chronic Kidney Disease (CKD) Product
    Table 91. FibroGen Revenue in Chronic Kidney Disease (CKD) Business (2016-2021) & (US$ Million)
    Table 92. FibroGen Recent Development
    Table 93. GlaxoSmithKline Company Details
    Table 94. GlaxoSmithKline Business Overview
    Table 95. GlaxoSmithKline Chronic Kidney Disease (CKD) Product
    Table 96. GlaxoSmithKline Revenue in Chronic Kidney Disease (CKD) Business (2016-2021) & (US$ Million)
    Table 97. GlaxoSmithKline Recent Development
    Table 98. Johnson & Johnson Company Details
    Table 99. Johnson & Johnson Business Overview
    Table 100. Johnson & Johnson Revenue in Chronic Kidney Disease (CKD) Business (2016-2021) & (US$ Million)
    Table 101. Johnson & Johnson Recent Development
    Table 102. Keryx Company Details
    Table 103. Keryx Business Overview
    Table 104. Keryx Chronic Kidney Disease (CKD) Product
    Table 105. Keryx Revenue in Chronic Kidney Disease (CKD) Business (2016-2021) & (US$ Million)
    Table 106. Keryx Recent Development
    Table 107. Kissei Company Details
    Table 108. Kissei Business Overview
    Table 109. Kissei Chronic Kidney Disease (CKD) Product
    Table 110. Kissei Revenue in Chronic Kidney Disease (CKD) Business (2016-2021) & (US$ Million)
    Table 111. Kissei Recent Development
    Table 112. Pfizer Company Details
    Table 113. Pfizer Business Overview
    Table 114. Pfizer Chronic Kidney Disease (CKD) Product
    Table 115. Pfizer Revenue in Chronic Kidney Disease (CKD) Business (2016-2021) & (US$ Million)
    Table 116. Pfizer Recent Development
    Table 117. Sanofi Company Details
    Table 118. Sanofi Business Overview
    Table 119. Sanofi Chronic Kidney Disease (CKD) Product
    Table 120. Sanofi Revenue in Chronic Kidney Disease (CKD) Business (2016-2021) & (US$ Million)
    Table 121. Sanofi Recent Development
    Table 122. Teva Company Details
    Table 123. Teva Business Overview
    Table 124. Teva Chronic Kidney Disease (CKD) Product
    Table 125. Teva Revenue in Chronic Kidney Disease (CKD) Business (2016-2021) & (US$ Million)
    Table 126. Teva Recent Development
    Table 127. Research Programs/Design for This Report
    Table 128. Key Data Information from Secondary Sources
    Table 129. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Chronic Kidney Disease (CKD) Market Share by Type: 2020 VS 2027
    Figure 2. ACE Inhibitors Features
    Figure 3. Calcium Channel Blockers Features
    Figure 4. Beta Blockers Features
    Figure 5. Others Features
    Figure 6. Global Chronic Kidney Disease (CKD) Market Share by Application: 2020 VS 2027
    Figure 7. Hospitals Case Studies
    Figure 8. Specialty Clinics Case Studies
    Figure 9. Chronic Kidney Disease (CKD) Report Years Considered
    Figure 10. Global Chronic Kidney Disease (CKD) Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 11. Global Chronic Kidney Disease (CKD) Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Chronic Kidney Disease (CKD) Market Share by Regions: 2020 VS 2027
    Figure 13. Global Chronic Kidney Disease (CKD) Market Share by Regions (2022-2027)
    Figure 14. Global Chronic Kidney Disease (CKD) Market Share by Players in 2020
    Figure 15. Global Top Chronic Kidney Disease (CKD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Kidney Disease (CKD) as of 2020
    Figure 16. The Top 10 and 5 Players Market Share by Chronic Kidney Disease (CKD) Revenue in 2020
    Figure 17. Global Chronic Kidney Disease (CKD) Revenue Market Share by Type (2016-2021)
    Figure 18. Global Chronic Kidney Disease (CKD) Revenue Market Share by Type (2022-2027)
    Figure 19. North America Chronic Kidney Disease (CKD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 20. North America Chronic Kidney Disease (CKD) Market Share by Type (2016-2027)
    Figure 21. North America Chronic Kidney Disease (CKD) Market Share by Application (2016-2027)
    Figure 22. North America Chronic Kidney Disease (CKD) Market Share by Country (2016-2027)
    Figure 23. United States Chronic Kidney Disease (CKD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Canada Chronic Kidney Disease (CKD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Chronic Kidney Disease (CKD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Chronic Kidney Disease (CKD) Market Share by Type (2016-2027)
    Figure 27. Europe Chronic Kidney Disease (CKD) Market Share by Application (2016-2027)
    Figure 28. Europe Chronic Kidney Disease (CKD) Market Share by Country (2016-2027)
    Figure 29. Germany Chronic Kidney Disease (CKD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. France Chronic Kidney Disease (CKD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. U.K. Chronic Kidney Disease (CKD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Italy Chronic Kidney Disease (CKD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Russia Chronic Kidney Disease (CKD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Nordic Chronic Kidney Disease (CKD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Chronic Kidney Disease (CKD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Chronic Kidney Disease (CKD) Market Share by Type (2016-2027)
    Figure 37. Asia-Pacific Chronic Kidney Disease (CKD) Market Share by Application (2016-2027)
    Figure 38. Asia-Pacific Chronic Kidney Disease (CKD) Market Share by Region (2016-2027)
    Figure 39. China Chronic Kidney Disease (CKD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Japan Chronic Kidney Disease (CKD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. South Korea Chronic Kidney Disease (CKD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Southeast Asia Chronic Kidney Disease (CKD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. India Chronic Kidney Disease (CKD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Australia Chronic Kidney Disease (CKD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Chronic Kidney Disease (CKD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Chronic Kidney Disease (CKD) Market Share by Type (2016-2027)
    Figure 47. Latin America Chronic Kidney Disease (CKD) Market Share by Application (2016-2027)
    Figure 48. Latin America Chronic Kidney Disease (CKD) Market Share by Country (2016-2027)
    Figure 49. Mexico Chronic Kidney Disease (CKD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Brazil Chronic Kidney Disease (CKD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Chronic Kidney Disease (CKD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Chronic Kidney Disease (CKD) Market Share by Type (2016-2027)
    Figure 53. Middle East & Africa Chronic Kidney Disease (CKD) Market Share by Application (2016-2027)
    Figure 54. Middle East & Africa Chronic Kidney Disease (CKD) Market Share by Country (2016-2027)
    Figure 55. Turkey Chronic Kidney Disease (CKD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Saudi Arabia Chronic Kidney Disease (CKD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. UAE Chronic Kidney Disease (CKD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. AbbVie Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2016-2021)
    Figure 59. Allergan Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2016-2021)
    Figure 60. Amgen Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2016-2021)
    Figure 61. AstraZeneca Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2016-2021)
    Figure 62. Roche Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2016-2021)
    Figure 63. FibroGen Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2016-2021)
    Figure 64. GlaxoSmithKline Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2016-2021)
    Figure 65. Johnson & Johnson Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2016-2021)
    Figure 66. Keryx Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2016-2021)
    Figure 67. Kissei Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2016-2021)
    Figure 68. Pfizer Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2016-2021)
    Figure 69. Sanofi Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2016-2021)
    Figure 70. Teva Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2016-2021)
    Figure 71. Bottom-up and Top-down Approaches for This Report
    Figure 72. Data Triangulation
    Figure 73. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AbbVie
Allergan
Amgen
AstraZeneca
Roche
FibroGen
GlaxoSmithKline
Johnson & Johnson
Keryx
Kissei
Pfizer
Sanofi
Teva
Frequently Asked Questions
Chronic Kidney Disease (CKD) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Chronic Kidney Disease (CKD) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Chronic Kidney Disease (CKD) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports